• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Am Soc Nephrol . Postmortem Kidney Pathology Findings in Patients with COVID-19

tetano

Editor, Senior Moderator
J Am Soc Nephrol


. 2020 Jul 29;ASN.2020050744.
doi: 10.1681/ASN.2020050744. Online ahead of print.
Postmortem Kidney Pathology Findings in Patients with COVID-19


Dominick Santoriello[SUP] 1 [/SUP], Pascale Khairallah[SUP] 2 [/SUP], Andrew S Bomback[SUP] 2 [/SUP], Katherine Xu[SUP] 2 [/SUP], Satoru Kudose[SUP] 1 [/SUP], Ibrahim Batal[SUP] 1 [/SUP], Jonathan Barasch[SUP] 2 [/SUP], Jai Radhakrishnan[SUP] 2 [/SUP], Vivette D'Agati[SUP] 1 [/SUP], Glen Markowitz[SUP] 3 [/SUP]



Affiliations

Abstract

Background: AKI is common among hospitalized patients with coronavirus disease 2019 (COVID-19) and is an independent risk factor for mortality. Although there are numerous potential mechanisms underlying COVID-19-associated AKI, our current knowledge of kidney pathologic findings in COVID-19 is limited.
Methods: We examined the postmortem kidneys from 42 patients who died of COVID-19. We reviewed light microscopy findings in all autopsies and performed immunofluorescence, electron microscopy, and in situ hybridization studies for SARS-CoV-2 on a subset of samples.
Results: The cohort had a median age of 71.5 years (range, 38-97 years); 69% were men, 57% were Hispanic, and 73% had a history of hypertension. Among patients with available data, AKI developed in 31 of 33 patients (94%), including 6 with AKI stage 1, 9 with stage 2, and 16 with stage 3. The predominant finding correlating with AKI was acute tubular injury. However, the degree of acute tubular injury was often less severe than predicted for the degree of AKI, suggesting a role for hemodynamic factors, such as aggressive fluid management. Background changes of hypertensive arterionephrosclerosis and diabetic glomerulosclerosis were frequent but typically mild. We identified focal kidney fibrin thrombi in 6 of 42 (14%) autopsies. A single Black patient had collapsing FSGS. Immunofluorescence and electron microscopy were largely unrevealing, and in situ hybridization for SARS-CoV-2 showed no definitive positivity.
Conclusions: Among a cohort of 42 patients dying with COVID-19, autopsy histologic evaluation revealed acute tubular injury, which was typically mild relative to the degree of creatinine elevation. These findings suggest potential for reversibility upon resolution of SARS-CoV-2 infection.

Keywords: COVID-19; SARS-CoV-2; acute kidney injury; acute renal failure; acute tubular injury; pathology.
 
Back
Top Bottom